See every side of every news story
Published loading...Updated

Jérôme Berger announced as strategy and finance executive at Vect-Horus - Pharmafile

Summary by pharmafile.com
Vect-Horus, a private biotechnology company specialising in molecular development, has announced the appointment of Jérôme Berger to its board of directors. Mr Berger bring experience from his previous role at Orange Group as president and managing partner. From this role, he garnered experience by overseeing investments in technology start-ups.  As global head of financing and […] The post Jérôme Berger announced as strategy and finance executi…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

pharmafile.com broke the news in on Tuesday, January 28, 2025.
Sources are mostly out of (0)